Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Liposome Drug Delivery Market Size study, by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others), by Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology), by Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Regional Forecasts 2022-2028

  • BIZ4983188
  • 200 Pages
  • June 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Liposome Drug Delivery Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Liposomes are becoming increasingly used as nano-carriers for a variety of pharmacological purposes. Phospholipid and cholesterol compositions are becoming more helpful in liposome medication delivery. Nanotechnology, on the other hand, is improving liposome medication delivery. The factors that propelled the growth of liposome drug delivery market are rise in cases of chronic conditions and increased disease control in patients suffering from colorectal cancer. For instance, as per cancer.net, in the United States, an estimated 151,030 persons will be diagnosed with colorectal cancer this year. 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer were reported. Colorectal cancer is the third most often diagnosed cancer worldwide. In 2020, it is expected that 1,880,725 individuals will be diagnosed with colorectal cancer. Also, According to World Health Organization data from 2018, cardiovascular disease (CVD) was the top cause of death in Mexico in 2016, accounting for approximately 24% of all fatalities. According to the American Heart Association, cardiovascular disease (CVD) was the underlying cause of death in 840,678 fatalities in the United States in 2016. However, high costs involved in the development of drug delivery systems impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Liposome Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market share globally, owing to increasing research and development and rise in cancer prevalence in this region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast period 2022-2028. Factors such as huge investment in research and development, rapidly aging population would create lucrative growth prospects for the Liposome Drug Delivery market across Asia-Pacific region.

Major market players included in this report are:

Spectrum Pharmaceuticals, Inc.

Takeda Pharmaceutical Company Limited

Ipsen Pharma

Celsion Corporation

Gilead Sciences, Inc.

Astellas Pharma, Inc.

Johnson & Johnson

Luye Pharma Group

Novartis AG

Pacira BioSciences, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Liposomal Doxorubicin

Liposomal Paclitaxel

Liposomal Amphotericin B

Others

By Technology:

Stealth Liposome Technology

Non-PEGylated Liposome Technology

DepoFoam Liposome Technology

By Application:

Fungal Diseases

Cancer Therapy

Pain Management

Viral Vaccines

Photodynamic Therapy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Liposome Drug Delivery Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Liposome Drug Delivery Market, by Region, 2020-2028 (USD Million)

1.2.2. Liposome Drug Delivery Market, by Product, 2020-2028 (USD Million)

1.2.3. Liposome Drug Delivery Market, by Technology, 2020-2028 (USD Million)

1.2.4. Liposome Drug Delivery Market, by Application, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Liposome Drug Delivery Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Liposome Drug Delivery Market Dynamics

3.1. Liposome Drug Delivery Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Rise in cases of chronic conditions

3.1.1.2. Increased disease control in patients suffering from colorectal cancer

3.1.2. Market Challenges

3.1.2.1. High Costs Involved in Development of Drug Delivery Systems

3.1.3. Market Opportunities

3.1.3.1. Huge investment in research and development

3.1.3.2. Rapidly aging population

Chapter 4. Global Liposome Drug Delivery Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Liposome Drug Delivery Market, by Technology

6.1. Market Snapshot

6.2. Global Liposome Drug Delivery Market by Technology, Performance - Potential Analysis

6.3. Global Liposome Drug Delivery Market Estimates & Forecasts by Technology, 2018-2028 (USD Million)

6.4. Liposome Drug Delivery Market, Sub Segment Analysis

6.4.1. Stealth Liposome Technology

6.4.2. Non-PEGylated Liposome Technology

6.4.3. DepoFoam Liposome Technology

Chapter 7. Global Liposome Drug Delivery Market, by Product

7.1. Market Snapshot

7.2. Global Liposome Drug Delivery Market by Product, Performance - Potential Analysis

7.3. Global Liposome Drug Delivery Market Estimates & Forecasts by Product, 2018-2028 (USD Million)

7.4. Liposome Drug Delivery Market, Sub Segment Analysis

7.4.1. Liposomal Doxorubicin

7.4.2. Liposomal Paclitaxel

7.4.3. Liposomal Amphotericin B

7.4.4. Others

Chapter 8. Global Liposome Drug Delivery Market, by Application

8.1. Market Snapshot

8.2. Global Liposome Drug Delivery Market by Application, Performance - Potential Analysis

8.3. Global Liposome Drug Delivery Market Estimates & Forecasts by Application, 2018-2028 (USD Million)

8.4. Liposome Drug Delivery Market, Sub Segment Analysis

8.4.1. Fungal Diseases

8.4.2. Cancer Therapy

8.4.3. Pain Management

8.4.4. Viral Vaccines

8.4.5. Photodynamic Therapy

Chapter 9. Global Liposome Drug Delivery Market, Regional Analysis

9.1. Liposome Drug Delivery Market, Regional Market Snapshot

9.2. North America Liposome Drug Delivery Market

9.2.1. U.S. Liposome Drug Delivery Market

9.2.1.1. Product breakdown estimates & forecasts, 2018-2028

9.2.1.2. Technology breakdown estimates & forecasts, 2018-2028

9.2.1.3. Application breakdown estimates & forecasts, 2018-202

9.2.2. Canada Liposome Drug Delivery Market

9.3. Europe Liposome Drug Delivery Market Snapshot

9.3.1. U.K. Liposome Drug Delivery Market

9.3.2. Germany Liposome Drug Delivery Market

9.3.3. France Liposome Drug Delivery Market

9.3.4. Spain Liposome Drug Delivery Market

9.3.5. Italy Liposome Drug Delivery Market

9.3.6. Rest of Europe Liposome Drug Delivery Market

9.4. Asia-Pacific Liposome Drug Delivery Market Snapshot

9.4.1. China Liposome Drug Delivery Market

9.4.2. India Liposome Drug Delivery Market

9.4.3. Japan Liposome Drug Delivery Market

9.4.4. Australia Liposome Drug Delivery Market

9.4.5. South Korea Liposome Drug Delivery Market

9.4.6. Rest of Asia Pacific Liposome Drug Delivery Market

9.5. Latin America Liposome Drug Delivery Market Snapshot

9.5.1. Brazil Liposome Drug Delivery Market

9.5.2. Mexico Liposome Drug Delivery Market

9.6. Rest of The World Liposome Drug Delivery Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Pacira BioSciences, Inc.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Spectrum Pharmaceuticals, Inc.

10.2.3. Takeda Pharmaceutical Company Limited

10.2.4. Ipsen Pharma

10.2.5. Celsion Corporation

10.2.6. Gilead Sciences, Inc.

10.2.7. Astellas Pharma, Inc.

10.2.8. Johnson & Johnson

10.2.9. Luye Pharma Group

10.2.10. Novartis AG

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Liposome Drug Delivery Market, report scope

TABLE 2. Global Liposome Drug Delivery Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Liposome Drug Delivery Market estimates & forecasts by Product 2018-2028 (USD Million)

TABLE 4. Global Liposome Drug Delivery Market estimates & forecasts by Technology 2018-2028 (USD Million)

TABLE 5. Global Liposome Drug Delivery Market estimates & forecasts by Application 2018-2028 (USD Million)

TABLE 6. Global Liposome Drug Delivery Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Liposome Drug Delivery Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Liposome Drug Delivery Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Liposome Drug Delivery Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Liposome Drug Delivery Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Liposome Drug Delivery Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Liposome Drug Delivery Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Liposome Drug Delivery Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Liposome Drug Delivery Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. Global Liposome Drug Delivery Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 17. U.S. Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. U.S. Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 19. Canada Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 20. Canada Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. Canada Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 22. UK Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 23. UK Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. UK Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 25. Germany Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 26. Germany Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. Germany Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 28. RoE Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 29. RoE Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. RoE Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 31. China Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 32. China Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. China Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 34. India Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 35. India Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. India Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 37. Japan Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 38. Japan Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. Japan Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 40. RoAPAC Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 41. RoAPAC Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. RoAPAC Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 43. Brazil Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 44. Brazil Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Brazil Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 46. Mexico Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 47. Mexico Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. Mexico Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 49. RoLA Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 50. RoLA Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. RoLA Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 52. Row Liposome Drug Delivery Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 53. Row Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. Row Liposome Drug Delivery Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 55. List of secondary sources, used in the study of global Liposome Drug Delivery Market

TABLE 56. List of primary sources, used in the study of global Liposome Drug Delivery Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research